JP2023534279A5 - - Google Patents

Info

Publication number
JP2023534279A5
JP2023534279A5 JP2023502926A JP2023502926A JP2023534279A5 JP 2023534279 A5 JP2023534279 A5 JP 2023534279A5 JP 2023502926 A JP2023502926 A JP 2023502926A JP 2023502926 A JP2023502926 A JP 2023502926A JP 2023534279 A5 JP2023534279 A5 JP 2023534279A5
Authority
JP
Japan
Prior art keywords
lipid
compound according
radical
lipophilic
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023502926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/070020 external-priority patent/WO2022013439A1/en
Publication of JP2023534279A publication Critical patent/JP2023534279A/ja
Publication of JP2023534279A5 publication Critical patent/JP2023534279A5/ja
Pending legal-status Critical Current

Links

JP2023502926A 2020-07-17 2021-07-16 切断可能な脂質化合物、それを含む組成物、およびその使用 Pending JP2023534279A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20305824 2020-07-17
EP20305824.3 2020-07-17
PCT/EP2021/070020 WO2022013439A1 (en) 2020-07-17 2021-07-16 Cleavable lipidic compounds, compositions containing thereof, and uses thereof

Publications (2)

Publication Number Publication Date
JP2023534279A JP2023534279A (ja) 2023-08-08
JP2023534279A5 true JP2023534279A5 (cg-RX-API-DMAC10.html) 2024-07-12

Family

ID=72292467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502926A Pending JP2023534279A (ja) 2020-07-17 2021-07-16 切断可能な脂質化合物、それを含む組成物、およびその使用

Country Status (11)

Country Link
US (1) US20230293447A1 (cg-RX-API-DMAC10.html)
EP (1) EP4182296A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023534279A (cg-RX-API-DMAC10.html)
KR (1) KR20230039713A (cg-RX-API-DMAC10.html)
CN (1) CN116194084A (cg-RX-API-DMAC10.html)
AU (1) AU2021308441A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023000568A2 (cg-RX-API-DMAC10.html)
CA (1) CA3189373A1 (cg-RX-API-DMAC10.html)
IL (1) IL299786A (cg-RX-API-DMAC10.html)
MX (1) MX2023000802A (cg-RX-API-DMAC10.html)
WO (1) WO2022013439A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025141521A1 (en) 2023-12-29 2025-07-03 Sanofi Lipids having dendritic moieties
WO2026053147A1 (en) 2024-09-05 2026-03-12 Sanofi Pasteur Inc. Helper lipids and lnp compositions comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201801428RA (en) 2013-08-21 2018-03-28 Curevac Ag Method for increasing expression of rna-encoded proteins
WO2016027699A1 (ja) * 2014-08-18 2016-02-25 日油株式会社 核酸送達のためのカチオン性脂質
JP6480025B2 (ja) * 2015-06-24 2019-03-06 日東電工株式会社 イオン性化合物及び組成物並びにその使用
DK3386484T3 (da) * 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
WO2017212009A1 (en) * 2016-06-09 2017-12-14 Curevac Ag Hybrid carriers for nucleic acid cargo
KR20190093816A (ko) * 2016-10-26 2019-08-26 큐어백 아게 지질 나노입자 mRNA 백신
US10383952B2 (en) * 2016-12-21 2019-08-20 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
US10526284B2 (en) * 2016-12-21 2020-01-07 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
EP3638678B1 (en) * 2017-06-14 2025-12-03 ModernaTX, Inc. Compounds and compositions for intracellular delivery of agents
WO2020219876A1 (en) * 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles

Similar Documents

Publication Publication Date Title
JP2022530043A5 (cg-RX-API-DMAC10.html)
JP6103605B2 (ja) 新規マンガン含有ナノ構造
EP0584315B1 (fr) Composition cosmetique et/ou pharmaceutique contenant une dispersion de vesicules lipidiques, procede de preparation de ladite dispersion et dispersion de vesicules lipidiques
JP6063627B2 (ja) 診断イメージング用のナノ粒子造影剤
JP2022539089A5 (cg-RX-API-DMAC10.html)
JP6762094B2 (ja) 薬剤のデリバリーのためのジスルフィド化合物
JP2024542188A5 (cg-RX-API-DMAC10.html)
JP2023505316A5 (cg-RX-API-DMAC10.html)
US20030180491A1 (en) Use of buckysome or carbon nanotube for drug delivery
EP3298066B1 (en) Dendri-tac and their use as theranostics
JP2024546951A5 (cg-RX-API-DMAC10.html)
JPH05501861A (ja) 界面活性剤の性質を有するフッ素およびリン含有両親媒性分子
JP2010505873A5 (ja) 化合物、会合複合体、及び会合複合体を形成する方法
JP6251744B2 (ja) MRI用の両親媒性錯体を含む常磁性固体脂質ナノ粒子(pSLN)
FR2665705A1 (fr) Nouveaux derives fluores amphiphiles a structure telomere, leur procede de preparation et leur utilisation dans des preparations a usage biomedical.
CN1172436A (zh) 可延长血液潴留的诊断成像用造影剂
US20040166152A1 (en) Use of buckysome or carbon nanotube for drug delivery
US20080193490A1 (en) Use of Carbon Nanotube for Drug Delivery
WO2006100305A2 (fr) Chelates métalliques de dérivés macrocycliques polyaminocarboxyliques et leur utilisation en imagerie diagnostique
EP2030632A1 (en) A carrier particle for use in bio-applications
TW201139421A (en) Novel ep4 agonist
JP2025524769A5 (cg-RX-API-DMAC10.html)
US12396949B2 (en) Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom
JP2025512340A5 (cg-RX-API-DMAC10.html)
JP2008297268A (ja) ジエチレントリアミン型金属キレート構造を有する高級脂肪酸トリエステル化合物